共 50 条
- [49] Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21): : 2006 - 2017
- [50] Ipilimumab/ipilimumab/nivolumabVarious toxicities: 5 case reports [J]. Reactions Weekly, 2022, 1887 (1) : 394 - 394